Sinus Bradycardia

Treat sinus bradycardia as unstable when it is accompanied by hypotension or other evidence of hemodynamic compromise. Obtain continuous ECG monitoring, establish pacing readiness, and correct immediately reversible precipitants while preparing temporizing therapy. Reported management of hemodynamically compromising sinus bradycardia has required inotropic support and transcutaneous pacing, with improvement in heart rate and hypotension. BMJBMJSinus bradycardia with haemodynamic compromise following ...

Use transcutaneous pacing when rapid rate support is needed, particularly when drug treatment is ineffective or a reversible cause cannot be corrected promptly. Beta-adrenergic agonists, transcutaneous pacing, and temporary transvenous pacing are acute options for bradycardia; temporary transvenous pacing is also first-line therapy for bradycardia-dependent ventricular tachycardia. Wiley+1Wiley[PDF] Pediatric antiarrhythmics and toxicity - Wiley Online Libraryjournal chestnetTemporary Transvenous Cardiac Pacing in the Critical Care Setting

Atropine can increase heart rate in sinus bradycardia; observational data cited in the ACC/AHA/HRS evidence supplement report effectiveness with 0.5 to 1 mg, but ventricular fibrillation, ventricular tachyarrhythmia, and sinus tachycardia occurred in some patients with acute myocardial infarction. Escalate rather than repeatedly delay pacing when clinical perfusion remains inadequate. ACCACC[PDF] Study Acronym; - American College of Cardiology

The pivotal diagnostic task is to link symptoms to bradycardia or pauses. Fatigue, presyncope, syncope, and exercise intolerance become actionable when recorded concurrently with sinus bradycardia, sinus arrest, or failure of rate augmentation. Permanent pacing is indicated for symptomatic patients with documented bradycardia responsible for symptoms and for demonstrated chronotropic incompetence. NEJM+1NEJMCardiac Pacing | New England Journal of MedicinePubMedSick Sinus Syndrome - StatPearls - NCBI Bookshelf

Evaluate for tachy-brady syndrome when atrial tachyarrhythmias alternate with sinus bradycardia or prolonged post-tachyarrhythmia pauses. This pattern is especially important when beta-blockers are required for atrial fibrillation but suppress sinus-node function, producing prolonged pauses and syncope after tachyarrhythmia termination; pacing can permit necessary therapy when the medication cannot be safely withdrawn. PubMedPubMedSick Sinus Syndrome - StatPearls - NCBI Bookshelf

Do not equate physiologic training-related sinus bradycardia with sinus-node disease. In athletes, sinus bradycardia may reflect exercise-induced electrical remodeling, increased vagal tone, and intrinsic changes in sinus automaticity and AV nodal function. Symptoms, abnormal chronotropic response, pathologic pauses, or nonphysiologic ECG findings should redirect evaluation toward sinus-node or conduction-system disease. jaccjaccThe Athlete’s ECG: Sport-Specific Patterns, Physiological Remodeling, and Clinical Interpretation

Perform a directed medication reconciliation, including prescription agents, ophthalmic preparations, antiarrhythmics, and recent dose changes. The bradycardia guideline identifies medications as frequent culprits, and antiarrhythmic drugs can precipitate or worsen bradycardia in patients with sinus-node dysfunction or abnormal AV conduction. If a drug is nonessential, withhold or reduce it and reassess heart rate and symptoms. AHA Journals+1AHA Journals2018 ACC/AHA/HRS Guideline on the Evaluation and Management ...AHA Journals2014 AHA/ACC/HRS Guideline for the Management of Patients With ...

Search for acquired contributors that alter management: metabolic derangements, ischemia, inflammatory or infiltrative disease, infection, toxic exposure, trauma, radiation, and iatrogenic injury are recognized causes of bradycardia and conduction disease. Direct testing to the clinical context—for example, targeted metabolic testing in an acutely ill patient, ischemic evaluation when symptoms or ECG suggest ischemia, and medication/toxin review after an exposure history—rather than assuming degenerative sinus-node disease. ACCACCNew in Clinical Documents | New Guideline Outlines Recommendations For Evaluating Managing Bradycardia - American College of Cardiology

Screen for sleep-disordered breathing when bradycardia is nocturnal or when the history suggests obstructive sleep apnea. Nocturnal bradycardias are common in sleep-disordered breathing and should prompt sleep-apnea assessment; they do not independently justify permanent pacing. ACCACCNew in Clinical Documents | New Guideline Outlines Recommendations For Evaluating Managing Bradycardia - American College of Cardiology

Age-related progressive fibrosis of the sinus node and adjacent atrial myocardium is a common substrate for sinus-node dysfunction. This diagnosis becomes more likely when symptomatic bradycardia persists after medication, systemic, sleep-related, ischemic, infectious, and iatrogenic contributors have been addressed. ACCACCNew in Clinical Documents | New Guideline Outlines Recommendations For Evaluating Managing Bradycardia - American College of Cardiology

Offer permanent pacemaker evaluation when symptoms are attributable to documented sinus bradycardia, sinus pauses, or chronotropic incompetence after reversible factors are corrected. Documented symptomatic bradycardia due to sinus-node dysfunction is a class I pacing indication in cited pacing guidance. NEJM+1NEJMCardiac Pacing | New England Journal of MedicinePubMedSick Sinus Syndrome - StatPearls - NCBI Bookshelf

A second pacing pathway is medication necessity: when sinus-node dysfunction is worsened by medication required for another condition, particularly tachy-brady syndrome requiring beta-adrenergic blockade for atrial fibrillation, pacing may prevent prolonged post-conversion pauses and syncope while allowing treatment of the tachyarrhythmia. PubMedPubMedSick Sinus Syndrome - StatPearls - NCBI Bookshelf

For sinus-node dysfunction requiring a dual-chamber device, program to minimize unnecessary ventricular pacing. In the largest cited dual-chamber leadless pacemaker study, sinus-node dysfunction was the most common implant indication, accounting for 63.3% of implants; device choice should still be individualized to anatomy, anticipated pacing needs, AV conduction, and procedural considerations. NEJM+1NEJMA Dual-Chamber Leadless Pacemaker | New England Journal of ...ACC2021 ESC Guidelines on Cardiac Pacing and CRT: Key Points - American College of Cardiology

When syncope coexists with bifascicular block, do not assume isolated sinus-node dysfunction. After unrevealing noninvasive evaluation, electrophysiology study should be considered; pacing is indicated with a baseline His-ventricular interval of at least 70 ms, inducible second- or third-degree intra- or infra-Hisian block during incremental atrial pacing, or abnormal pharmacologic challenge response. Alternating bundle-branch block is itself an indication for pacing regardless of symptoms. ACCACC2021 ESC Guidelines on Cardiac Pacing and CRT: Key Points - American College of Cardiology

After withdrawal of a suspected culprit medication or treatment of an identified reversible factor, reassess symptoms and rhythm before proceeding to permanent pacing. A persistent temporal relationship between bradycardia and presyncope, syncope, fatigue, or exercise limitation favors intrinsic sinus-node dysfunction; resolution after cause-directed treatment favors a reversible diagnosis. AHA Journals+2AHA Journals2018 ACC/AHA/HRS Guideline on the Evaluation and Management ...ACCNew in Clinical Documents | New Guideline Outlines Recommendations For Evaluating Managing Bradycardia - American College of CardiologyPubMedSick Sinus Syndrome - StatPearls - NCBI Bookshelf

Patients with a pacemaker for sinus-node dysfunction should have programming reviewed to minimize unnecessary ventricular pacing when a dual-chamber device is used. This strategy is specifically recommended in ESC pacing guidance summarized by the ACC. ACCACC2021 ESC Guidelines on Cardiac Pacing and CRT: Key Points - American College of Cardiology

Reassess patients with atrial tachyarrhythmias for recurrent tachy-brady episodes after pacing and after changes in beta-blocker or antiarrhythmic therapy. Antiarrhythmics may worsen bradycardia in those with abnormal sinus-node or AV conduction, so rhythm-control decisions should be coordinated with the pacing plan. AHA Journals+1AHA Journals2014 AHA/ACC/HRS Guideline for the Management of Patients With ...PubMedSick Sinus Syndrome - StatPearls - NCBI Bookshelf